Pepgen to participate in the stifel 2022 healthcare conference

Boston, nov. 08, 2022 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that james mcarthur, ph.d., president and ceo of pepgen will present at stifel's 2022 annual healthcare conference in new york, new york on november 15th, 2022, at 9:45 a.m. et.
PEPG Ratings Summary
PEPG Quant Ranking